Buy Keytruda (Pembrolizumab) Drug

Medical Evidence

Generic name : Pembrolizumab.

Trade name : Keytruda.

Manufacturer information:

Keytruda is manufactured by Merck & Co., Inc.

Keytruda FDA Approval :

Keytruda first approved September 4th, 2014.

Keytruda Dosage form :

For injection: 50 mg, lyophilized powder in single-use vial for reconstitution.Injection: 100 mg/4 mL (25 mg/mL) solution in a single-use vial.

Keytruda Indications and Usage :

Melanoma

Indicated for unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation positive, a BRAF inhibitor.

Keytruda (Pembrolizumab) availability in India

• You could import this medicine against import permit on Patient Name.
• Please contact ACT Lifesciences Private Limited for further information.